COLA Publishes 2020 Laboratory Accreditation Manual with New and Revised Criteria for Accreditation Customers
Executives of COLA, a national laboratory accreditor for quality laboratory medicine and patient care, will attend the 2019 Executive War College on Lab and Pathology Management being held at the Sheraton Hotel in New Orleans April 30 – May 1, 2019.
The Executive War College is the premier conference for laboratory executives, administrators and pathologists and this year’s program addresses a vast landscape of topics which are vital to fully appreciating the financial, scientific, technological and social forces changing the laboratory industry.
“I know of no other national conference that covers laboratory issues with such breadth and depth,” said COLA CEO Nancy Stratton. “The Executive War College is an incredible opportunity for COLA to carry our mission to the industry while, at the same time, appreciate how our customers are being impacted by the magnitude of changes underway.”
COLA’s Chief Medical Officer, John Daly, MD, a well-known proponent for excellence in laboratory medicine will attend as well. “This year’s program offers a wealth of knowledge about how pathologists, executives, administrators, compliance officers and those passionate about quality can innovate to meet the new demands and take advantage of innovations in technology,” said Dr. Daly. “I look forward to learning from others and to sharing my knowledge with this distinguished group of speakers, panelists and peers. This is a conference I never miss.”
COLA accredits clinical laboratories operating in many different settings including hospitals, physician offices, rural and community clinics, student centers, health fairs, ambulatory surgery centers, health maintenance organizations, healthcare systems, federally qualified health centers, nursing facilities as well as independent laboratories. With the Executive War College’s extensive focus laboratory economics, COLA’s Controller, Tom Dehner, is also attending the event.
“I believe this conference is vital to COLA’s understanding of the financial challenges and opportunities facing our customers nationwide including how value-based healthcare is changing laboratory revenue models and the role of laboratory quality, safety and patient experience within the current and emerging models,” stated Mr. Dehner. “I am happy to be joining my colleagues at this event and I look forward to meeting a number of our customers in person.”
Related posts
